Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic dise…
What to know about PFE
Pfizer Inc. is a large Healthcare company with a mixed financial profile. It scores well on risk and size, but growth is worth keeping an eye on.
Should you consider PFE?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Pfizer Inc. is a large-cap Healthcare company with a mixed overall financial profile — it sits in the upper half of Healthcare stocks (23 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
There is a small dividend (0.07%), but income-focused investors will likely find better yields elsewhere in the market.
-
Risk is relatively low — the stock tends to be less volatile than the broader market, which typically means a smoother ride during uncertain periods.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how PFE compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 19.24 | Above avg |
| Forward P/E | 8.91 | Top 25% |
| PEG Ratio | 13.77 | Below avg |
| Price to Sales | 2.27 | Above avg |
| Price to Book | 1.59 | Top 25% |
| EV/EBITDA | 7.87 | Top 25% |
| Earnings Yield | 5.20% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 74.80% | Top 25% |
| Operating Margin | 31.62% | Top 25% |
| Net Profit Margin | 11.83% | Average |
| Return on Equity | 8.31% | Below avg |
| Return on Invested Capital | 5.69% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 5.40% | Average |
| Revenue Growth (3Y CAGR) | -14.80% | Below avg |
| EPS Growth (YoY) | -10.10% | Below avg |
| Free Cash Flow Growth | -7.73% | Average |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.25 | Above avg |
| Debt to Equity | 0.72 | Above avg |
| Interest Coverage | 3.82 | Average |
| Altman Z-Score | 1.98 | Average |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 6.61% | Top 25% |
| Payout Ratio | 131.30% | Below avg |
| Dividend Growth (5Y) | -11.23% | Below avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 6.60% | Above avg |
| OCF to Sales | 18.93% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.29 | Top 25% |
| Volatility (30-Day) | 17.45% | Top 25% |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 2.85% | Above avg |
| Avg. Analyst Rating | 2.41 | Below avg |
| Target Upside % | 15.78% | Above avg |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 143.68B | Top 25% |
How does PFE compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to PFE — based on their financial profile.